Ebers Pharmaceuticals Ltd


BSE: 507715 | NSE: NA | ISIN: INE669D01018 
Market Cap: [Rs.Cr.] 1 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsMar-01Mar-00Mar-99Mar-98Mar-97Mar-96
INCOME :      
Sales Turnover 0.190.080.330.7921.588.54
Excise Duty0.000.010.040.140.290.34
Net Sales0.190.070.290.6521.298.20
Other Income 0.250.070.910.262.720.69
Stock Adjustments 0.14-0.14-0.280.040.20-0.10
Total Income0.580.000.920.9524.218.79
EXPENDITURE :      
Raw Materials 0.230.000.220.3420.986.49
Power & Fuel Cost0.000.000.040.040.220.22
Employee Cost 0.080.070.201.301.440.97
Other Manufacturing Expenses 0.030.000.050.090.300.27
Selling and Administration Expenses 0.060.130.260.510.630.69
Miscellaneous Expenses 0.160.230.060.140.480.20
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure0.560.430.832.4224.058.84
Operating Profit0.02-0.430.09-1.470.16-0.05
Interest 0.010.040.120.161.260.20
Gross Profit0.01-0.47-0.03-1.63-1.10-0.25
Depreciation0.140.130.140.140.120.06
Profit Before Tax-0.13-0.60-0.17-1.77-1.22-0.31
Tax0.000.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.000.000.000.000.00
Reported Net Profit-0.13-0.60-0.17-1.77-1.22-0.31
Extraordinary Items 0.000.000.780.000.000.00
Adjusted Net Profit-0.13-0.60-0.95-1.77-1.22-0.31
Adjst. below Net Profit 0.000.000.00-0.060.000.00
P & L Balance brought forward-6.80-6.20-6.03-4.20-2.98-2.67
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down-6.93-6.80-6.20-6.03-4.20-2.98
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.000.00
Earnings Per Share-Unit Curr0.000.000.000.000.000.00
Earnings Per Share(Adj)-Unit Curr0.000.000.000.000.000.00
Book Value-Unit Curr-9.97-9.59-7.85-7.38-2.031.49
Book Value(Adj)-Unit Curr-9.97-9.59-7.85-7.38-2.031.49

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma 3,529.01 19.84 9.91 7.48 32.2 38.1 0.50
Kappac Pharma 1,679.88 0.00 55.29 0.00 0.0 0.0 0.06
Bliss GVS Pharma 508.28 8.74 1.96 2.75 24.2 40.6 0.17
Sharon Bio-Med. 501.89 8.02 2.66 8.13 24.2 13.8 2.64
Venus Remedies 350.81 5.90 0.86 4.21 16.1 14.4 0.69
Ahlcon Parent(I) 331.45 18.43 6.13 10.50 26.9 31.2 0.41
Syncom Formul. 322.43 59.00 3.69 14.09 6.6 9.8 0.05
Arvind Remedies 294.99 4.86 1.41 4.80 25.2 20.1 2.73
Caplin Point Lab 277.95 16.25 6.92 2.62 40.6 53.9 0.16
Mahavir Advanced 274.51 0.00 31.75 0.00 0.0 0.0 0.00
Amrutanjan Healt 204.47 15.16 2.33 7.12 14.4 19.8 0.20
Plethico Pharma. 139.52 0.00 0.26 35.79 -5.0 1.6 1.56
Zenotech Lab. 101.91 0.00 3.91 0.00 0.0 0.0 0.28
Parenteral Drugs 96.92 0.00 0.49 0.00 0.0 0.0 1.27
Hester Bios 83.91 10.26 1.24 5.68 15.2 21.7 0.32

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

A K Rathi , Chairman 

S M Parande , Managing Director 

R Goppu , Director 

Ashok B Raval , Director 


Company Head Office / Quarters:
103 Shreepal Complex Suren Rd,
Andheri (E),
Mumbai,
Maharashtra-400093
Phone : 91-22-8367527
Fax : 91-22-8218340
E-mail :
Web : http://
Registrars:
Bigshare Services Pvt Ltd
E-2/3 Ansa Indl Est
Saki Vihar Road
Sakinaka Andheri(E)
Mumbai - 400072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Apr-2014
M T W T F S S
21 22 23 24 25 26 27
IPO
listNo IPO today
Economic Events
list French Total Jobseekers Change
list French Total Jobseekers
Results
list Exide Inds. | A B B | Bosch | Siemens